Aesthetic Performance and Tolerance of an Injective Intradermal Treatment for the Skin Roughness and Laxity of Back of the Hands

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 7, 2022

Primary Completion Date

June 8, 2023

Study Completion Date

June 8, 2023

Conditions
Skin LaxitySkin Roughness
Interventions
DEVICE

Profhilo® Body

Dosage form: Profhilo® Body (IBSA Farmaceutici Italia S.r.l.) is a resorbable medical device 3.25 ml non-pyrogenic pre-filled syringe, containing 3 ml of 3.2% hyaluronic acid for intradermal use (48 mg H-HA + 48 mg L-HA) dissolved in 3 ml of saline buffered sodium chloride.

Trial Locations (1)

Unknown

DERMING S.r.l., Clinical Research and Bioengineering Institute, Milan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Derming SRL

OTHER

lead

IBSA Farmaceutici Italia Srl

INDUSTRY

NCT05590364 - Aesthetic Performance and Tolerance of an Injective Intradermal Treatment for the Skin Roughness and Laxity of Back of the Hands | Biotech Hunter | Biotech Hunter